These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 34369389)

  • 1. Antisense oligonucleotide treatment rescues UBE3A expression and multiple phenotypes of an Angelman syndrome mouse model.
    Milazzo C; Mientjes EJ; Wallaard I; Rasmussen SV; Erichsen KD; Kakunuri T; van der Sman ASE; Kremer T; Miller MT; Hoener MC; Elgersma Y
    JCI Insight; 2021 Aug; 6(15):. PubMed ID: 34369389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome.
    Lee D; Chen W; Kaku HN; Zhuo X; Chao ES; Soriano A; Kuncheria A; Flores S; Kim JH; Rivera A; Rigo F; Jafar-Nejad P; Beaudet AL; Caudill MS; Xue M
    Elife; 2023 Jan; 12():. PubMed ID: 36594817
    [No Abstract]   [Full Text] [Related]  

  • 3. Towards a therapy for Angelman syndrome by targeting a long non-coding RNA.
    Meng L; Ward AJ; Chun S; Bennett CF; Beaudet AL; Rigo F
    Nature; 2015 Feb; 518(7539):409-12. PubMed ID: 25470045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prenatal delivery of a therapeutic antisense oligonucleotide achieves broad biodistribution in the brain and ameliorates Angelman syndrome phenotype in mice.
    Clarke MT; Remesal L; Lentz L; Tan DJ; Young D; Thapa S; Namuduri SR; Borges B; Kirn G; Valencia J; Lopez ME; Lui JH; Shiow LR; Dindot S; Villeda S; Sanders SJ; MacKenzie TC
    Mol Ther; 2024 Apr; 32(4):935-951. PubMed ID: 38327047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the requirements of prenatal UBE3A expression for rescue of behavioral phenotypes in a mouse model for Angelman syndrome.
    Sonzogni M; Zhai P; Mientjes EJ; van Woerden GM; Elgersma Y
    Mol Autism; 2020 Sep; 11(1):70. PubMed ID: 32948244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE3A reinstatement as a disease-modifying therapy for Angelman syndrome.
    Elgersma Y; Sonzogni M
    Dev Med Child Neurol; 2021 Jul; 63(7):802-807. PubMed ID: 33543479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An ASO therapy for Angelman syndrome that targets an evolutionarily conserved region at the start of the
    Dindot SV; Christian S; Murphy WJ; Berent A; Panagoulias J; Schlafer A; Ballard J; Radeva K; Robinson R; Myers L; Jepp T; Shaheen H; Hillman P; Konganti K; Hillhouse A; Bredemeyer KR; Black L; Douville J; ;
    Sci Transl Med; 2023 Mar; 15(688):eabf4077. PubMed ID: 36947593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene Therapy for Angelman Syndrome: Contemporary Approaches and Future Endeavors.
    Tsagkaris C; Papakosta V; Miranda AV; Zacharopoulou L; Danilchenko V; Matiashova L; Dhar A
    Curr Gene Ther; 2020; 19(6):359-366. PubMed ID: 31914913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adult
    Rotaru DC; van Woerden GM; Wallaard I; Elgersma Y
    J Neurosci; 2018 Sep; 38(37):8011-8030. PubMed ID: 30082419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional reprogramming restores UBE3A brain-wide and rescues behavioral phenotypes in an Angelman syndrome mouse model.
    O'Geen H; Beitnere U; Garcia MS; Adhikari A; Cameron DL; Fenton TA; Copping NA; Deng P; Lock S; Halmai JANM; Villegas IJ; Liu J; Wang D; Fink KD; Silverman JL; Segal DJ
    Mol Ther; 2023 Apr; 31(4):1088-1105. PubMed ID: 36641623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR/Cas9 directed to the Ube3a antisense transcript improves Angelman syndrome phenotype in mice.
    Schmid RS; Deng X; Panikker P; Msackyi M; Breton C; Wilson JM
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33411694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Truncation of Ube3a-ATS unsilences paternal Ube3a and ameliorates behavioral defects in the Angelman syndrome mouse model.
    Meng L; Person RE; Huang W; Zhu PJ; Costa-Mattioli M; Beaudet AL
    PLoS Genet; 2013; 9(12):e1004039. PubMed ID: 24385930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ube3a reinstatement identifies distinct developmental windows in a murine Angelman syndrome model.
    Silva-Santos S; van Woerden GM; Bruinsma CF; Mientjes E; Jolfaei MA; Distel B; Kushner SA; Elgersma Y
    J Clin Invest; 2015 May; 125(5):2069-76. PubMed ID: 25866966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cas9 gene therapy for Angelman syndrome traps Ube3a-ATS long non-coding RNA.
    Wolter JM; Mao H; Fragola G; Simon JM; Krantz JL; Bazick HO; Oztemiz B; Stein JL; Zylka MJ
    Nature; 2020 Nov; 587(7833):281-284. PubMed ID: 33087932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. UBE3A expression during early postnatal brain development is required for proper dorsomedial striatal maturation.
    Rotaru DC; Wallaard I; de Vries M; van der Bie J; Elgersma Y
    JCI Insight; 2023 Feb; 8(4):. PubMed ID: 36810252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A high-fidelity RNA-targeting Cas13 restores paternal Ube3a expression and improves motor functions in Angelman syndrome mice.
    Li J; Shen Z; Liu Y; Yan Z; Liu Y; Lin X; Tang J; Lv R; Geng G; Xiong ZQ; Zhou C; Yang H
    Mol Ther; 2023 Jul; 31(7):2286-2295. PubMed ID: 36805082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ube3a reinstatement mitigates epileptogenesis in Angelman syndrome model mice.
    Gu B; Carstens KE; Judson MC; Dalton KA; Rougié M; Clark EP; Dudek SM; Philpot BD
    J Clin Invest; 2019 Jan; 129(1):163-168. PubMed ID: 30352049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Light activates Ube3a, an Angelman syndrome-associated gene, by mediating the chromatin structures during postnatal development of mouse retina.
    Lin CW; Cheng YC; Yang CH; Huang HS
    J Neurochem; 2023 Dec; 167(6):766-777. PubMed ID: 37994169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Maternal disruption of Ube3a leads to increased expression of Ube3a-ATS in trans.
    Landers M; Calciano MA; Colosi D; Glatt-Deeley H; Wagstaff J; Lalande M
    Nucleic Acids Res; 2005; 33(13):3976-84. PubMed ID: 16027444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imprinting effects of UBE3A loss on synaptic gene networks and Wnt signaling pathways.
    Lopez SJ; Laufer BI; Beitnere U; Berg EL; Silverman JL; O'Geen H; Segal DJ; LaSalle JM
    Hum Mol Genet; 2019 Nov; 28(22):3842-3852. PubMed ID: 31625566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.